Zinc and calcium ions cooperatively modulate ADAMTS13 activity

被引:70
作者
Anderson, PJ
Kokame, K
Sadler, JE
机构
[1] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA
[2] Natl Cardiovasc Ctr, Inst Res, Osaka 5658565, Japan
关键词
D O I
10.1074/jbc.M504540200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ADAMTS13 is a metalloproteinase that cleaves von Willebrand factor (VWF) multimers. The metal ion dependence of ADAMTS13 activity was examined with multimeric VWF and a fluorescent peptide substrate based on Asp(1596)-Arg(1668) of the VWF A2 domain, FRETS-VWF73. ADAMTS13 activity in citrate-anticoagulated plasma was enhanced similar to 2-fold by zinc ions, similar to 3-fold by calcium ions, and similar to 6-fold by both ions, suggesting cooperative activation. Cleavage of VWF by recombinant ADAMTS13 was activated up to similar to 200-fold by zinc ions (K-D (app) similar to 0.5 similar to M), calcium ions (K-D (app) similar to 4.8 similar to M), and barium ions (K-D (app) similar to 1.7 mM). Barium ions stimulated ADAMTS13 activity in citrated plasma but not in citrate-free plasma. Therefore, the stimulation by barium ions of ADAMTS13 in citrated plasma appears to reflect the release of chelated calcium and zinc ions from complexes with citrate. At optimal zinc and calcium concentrations, ADAMTS13 cleaved VWF with a Km app of 3.7 +/- 1.4 mu/ml (similar to 15 nM for VWF subunits), which is comparable with the plasma VWF concentration of 5-10 mu g/ml. ADAMTS13 could cleave similar to 14% of VWF pretreated with guanidine HCl, suggesting that this substrate is heterogeneous in susceptibility to proteolysis. ADAMTS13 cleaved FRETS-VWF73 with a K-m (app) of 3.2 +/- 1.1 mu M, consistent with an 200-fold decrease in affinity compared with VWF. ADAMTS13 cleaved VWF and FRETS-VWF73 with roughly comparable catalytic efficiency of 55 mu M-1 min(-1) and 18 mu M-1 min(-1), respectively. The striking preference of ADAMTS13 for VWF suggests that substrate recognition depends on structural features or exosites on multimeric VWF that are missing from FRETS-VWF73.
引用
收藏
页码:850 / 857
页数:8
相关论文
共 56 条
[41]   Biochemistry and genetics of von Willebrand factor [J].
Sadler, JE .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :395-424
[42]   CHARACTERIZATION OF ZINC-BINDING SITES IN HUMAN STROMELYSIN-1 - STOICHIOMETRY OF THE CATALYTIC DOMAIN AND IDENTIFICATION OF A CYSTEINE LIGAND IN THE PROENZYME [J].
SALOWE, SP ;
MARCY, AI ;
CUCA, GC ;
SMITH, CK ;
KOPKA, IE ;
HAGMANN, WK ;
HERMES, JD .
BIOCHEMISTRY, 1992, 31 (19) :4535-4540
[43]  
SEGEL IH, 1975, ENZYME KINETICS BEHA, P39
[44]   A novel human metalloprotease synthesized in the liver and secreted into the blood: Possibly, the von Willebrand factor-cleaving protease? [J].
Soejima, K ;
Mimura, N ;
Hirashima, M ;
Maeda, H ;
Hamamoto, T ;
Nakagaki, T ;
Nozaki, C .
JOURNAL OF BIOCHEMISTRY, 2001, 130 (04) :475-480
[45]  
STOCKER W, 1995, PROTEIN SCI, V4, P823
[46]   Molecular modeling of the von Willebrand factor A2 domain and the effects of associated type 2A von Willebrand disease mutations [J].
Sutherland, JJ ;
O'Brien, LA ;
Lillicrap, D ;
Weaver, DF .
JOURNAL OF MOLECULAR MODELING, 2004, 10 (04) :259-270
[47]   ADAMTS: a novel family of extracellular matrix proteases [J].
Tang, BL .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (01) :33-44
[48]   Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: Inhibition by doxycycline and by monoclonal antibody VP-1 [J].
Tsai, HM ;
Sussman, II ;
Ginsburg, D ;
Lankhof, H ;
Sixma, JJ ;
Nagel, RL .
BLOOD, 1997, 89 (06) :1954-1962
[49]   Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura [J].
Tsai, HM ;
Lian, ECY .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1585-1594
[50]   Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion [J].
Tsai, HM .
BLOOD, 1996, 87 (10) :4235-4244